[go: up one dir, main page]

FI820392L - PROCEDURE FOR THE PHARMACEUTICAL PROTECTION OF ACTIVE 2-AMINO-3- (HALOBENZOYL) -METHYLPHENYL ETHYROR-ESTRAR OCH DERAS SATER - Google Patents

PROCEDURE FOR THE PHARMACEUTICAL PROTECTION OF ACTIVE 2-AMINO-3- (HALOBENZOYL) -METHYLPHENYL ETHYROR-ESTRAR OCH DERAS SATER

Info

Publication number
FI820392L
FI820392L FI820392A FI820392A FI820392L FI 820392 L FI820392 L FI 820392L FI 820392 A FI820392 A FI 820392A FI 820392 A FI820392 A FI 820392A FI 820392 L FI820392 L FI 820392L
Authority
FI
Finland
Prior art keywords
ethyror
estrar
sater
halobenzoyl
methylphenyl
Prior art date
Application number
FI820392A
Other languages
Finnish (fi)
Other versions
FI73970B (en
FI73970C (en
Inventor
David Allan Walsh
Dwight Allen Shamblee
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of FI820392L publication Critical patent/FI820392L/en
Publication of FI73970B publication Critical patent/FI73970B/en
Application granted granted Critical
Publication of FI73970C publication Critical patent/FI73970C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C1/00—Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/32—Phenylacetic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/46—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings, e.g. cyclohexylphenylacetic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
FI820392A 1981-02-17 1982-02-08 FOERFARANDE FOER FRAMSTAELLNING AV PHARMACEUTISKT AKTIVA 2-AMINO-3- (HALOBENSOYL) -METHYL-PHENYL ETHYL OCH ESTRAR OCH SALTER DAERAV. FI73970C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23453181A 1981-02-17 1981-02-17
US23453181 1981-02-17

Publications (3)

Publication Number Publication Date
FI820392L true FI820392L (en) 1982-08-18
FI73970B FI73970B (en) 1987-08-31
FI73970C FI73970C (en) 1987-12-10

Family

ID=22881752

Family Applications (1)

Application Number Title Priority Date Filing Date
FI820392A FI73970C (en) 1981-02-17 1982-02-08 FOERFARANDE FOER FRAMSTAELLNING AV PHARMACEUTISKT AKTIVA 2-AMINO-3- (HALOBENSOYL) -METHYL-PHENYL ETHYL OCH ESTRAR OCH SALTER DAERAV.

Country Status (32)

Country Link
JP (1) JPS57149256A (en)
KR (1) KR880002289B1 (en)
AT (1) AT387213B (en)
AU (1) AU7950382A (en)
BE (1) BE892156A (en)
CA (1) CA1173852A (en)
CH (1) CH651294A5 (en)
DE (1) DE3204854C2 (en)
DK (1) DK155936C (en)
EG (1) EG15798A (en)
ES (1) ES509622A0 (en)
FI (1) FI73970C (en)
FR (1) FR2499981B1 (en)
GB (1) GB2093027B (en)
GR (1) GR76516B (en)
HK (1) HK90384A (en)
HU (1) HU187644B (en)
IE (1) IE52289B1 (en)
IL (1) IL64724A0 (en)
IT (1) IT1157001B (en)
KE (1) KE3454A (en)
LU (1) LU83928A1 (en)
MY (1) MY8500908A (en)
NL (1) NL8200607A (en)
NO (1) NO160133C (en)
NZ (1) NZ199745A (en)
PL (1) PL139815B1 (en)
PT (1) PT74441B (en)
SE (1) SE453387B (en)
SG (1) SG68584G (en)
YU (1) YU44333B (en)
ZA (1) ZA82697B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683242A (en) * 1985-10-28 1987-07-28 A. H. Robins Company, Incorporated Transdermal treatment for pain and inflammation with 2-amino-3-aroylbenzeneacetic acids, salts and esters
US5475034A (en) * 1994-06-06 1995-12-12 Alcon Laboratories, Inc. Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
BR9600975A (en) * 1996-03-11 1997-12-30 Fundacao Oswaldo Cruz Derivatives of gem-difluorphenylacetic acid and gem-difluorphenylacetamide process of their preparation and their pharmaceutical applications
US6034266A (en) * 1996-03-11 2000-03-07 Fundacao Oswaldo Cruz-Fiocruz Gem-difluoro derivative of phenylacetamide and phenylacetic acid and their pharmaceutical uses
AR030345A1 (en) * 2000-08-14 2003-08-20 Alcon Inc METHOD OF TREATMENT OF DISORDERS RELATED TO ANGIOGENESIS
AR030346A1 (en) * 2000-08-14 2003-08-20 Alcon Inc METHOD OF TREATMENT OF NEURODEGENERATIVE DISORDERS OF THE RETINA AND HEAD OF OPTICAL NERVE
US6646003B2 (en) 2001-04-02 2003-11-11 Alcon, Inc. Method of treating ocular inflammatory and angiogenesis-related disorders of the posterior segment of the eye using an amide derivative of flurbiprofen or ketorolac
TWI358290B (en) 2004-12-02 2012-02-21 Alcon Inc Topical nepafenac formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1226344A (en) * 1967-07-31 1971-03-24
US3997368A (en) * 1975-06-24 1976-12-14 Bell Telephone Laboratories, Incorporated Elimination of stacking faults in silicon devices: a gettering process
SE400966B (en) * 1975-08-13 1978-04-17 Robins Co Inc A H PROCEDURE FOR PREPARING 2-AMINO-3- (OR 5-) BENZOYL-PHENYLETIC ACIDS
FR2366015A1 (en) * 1975-11-05 1978-04-28 Robins Co Inc A H Amino-benzoyl-phenylacetic acid derivs - antiinflammatory, hypocholesterolemic and blood platelet agglomeration inhibitory activity
IL61945A (en) * 1980-02-19 1984-09-30 Robins Co Inc A H 2-amino-3-(hydroxy(phenyl)methyl)phenylacetic acids,esters and amides and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DK67382A (en) 1982-08-18
GB2093027A (en) 1982-08-25
KR830008990A (en) 1983-12-16
HK90384A (en) 1984-11-23
SE8200891L (en) 1982-08-18
SG68584G (en) 1985-03-15
PL139815B1 (en) 1987-02-28
JPS57149256A (en) 1982-09-14
DK155936C (en) 1989-11-06
ZA82697B (en) 1983-01-26
GB2093027B (en) 1984-07-04
ES8301895A1 (en) 1982-12-16
NO160133C (en) 1989-03-15
CH651294A5 (en) 1985-09-13
DK155936B (en) 1989-06-05
KE3454A (en) 1984-10-12
IT8267152A0 (en) 1982-02-10
JPH0365338B2 (en) 1991-10-11
DE3204854A1 (en) 1982-09-09
BE892156A (en) 1982-06-16
IT1157001B (en) 1987-02-11
FI73970B (en) 1987-08-31
IL64724A0 (en) 1982-03-31
NO820468L (en) 1982-08-18
AT387213B (en) 1988-12-27
KR880002289B1 (en) 1988-10-22
FR2499981B1 (en) 1986-05-23
IE52289B1 (en) 1987-09-02
PT74441A (en) 1982-03-01
ATA43382A (en) 1988-05-15
IE820310L (en) 1982-08-17
YU32582A (en) 1985-06-30
DE3204854C2 (en) 1994-06-16
LU83928A1 (en) 1983-06-07
PL235095A1 (en) 1982-11-08
NO160133B (en) 1988-12-05
AU7950382A (en) 1982-08-26
EG15798A (en) 1986-06-30
NZ199745A (en) 1985-07-12
CA1173852A (en) 1984-09-04
SE453387B (en) 1988-02-01
FR2499981A1 (en) 1982-08-20
NL8200607A (en) 1982-09-16
YU44333B (en) 1990-06-30
FI73970C (en) 1987-12-10
MY8500908A (en) 1985-12-31
ES509622A0 (en) 1982-12-16
HU187644B (en) 1986-02-28
PT74441B (en) 1983-08-24
GR76516B (en) 1984-08-10

Similar Documents

Publication Publication Date Title
NO162022C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CEFEM DERIVATIVES.
NO810765L (en) PROCEDURE FOR THE PREPARATION OF PHARMASOYYTIC ACTIVE CARBOSTYRIC DERIVATIVES.
NO156864B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PIPERIN DERIVATIVES.
NO156785B (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CYCLOBUTAN DERIVATIVES.
NO161117C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CEPHALOSPORIN DERIVATIVES.
NO820479L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOSTYRIL DERIVATIVES
NO152129C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OMEGA-CYAN-1, OMEGA-DIFENYL-AZAALKANDER DERIVATIVES
NO831610L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OXICAM DERIVATIVES.
FI853649L (en) FRUIT PROTECTION FOR PHARMACEUTICAL ACTIVATION OF ACTIVE 2- (PYRIDYLALKENSULFINYL) BENZIMIDAZOLER.
NO814136L (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 8-ARYLALKYL-3-PHENYL-3-NOTROPANOL DERIVATIVES
NO159654C (en) ANALOGY PROCEDURES FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-GUANIDIN-4-HETEROARYLTIAZOLD DERIVATIVES.
NO161676C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE MITOSANDER DERIVATIVES.
NO160079C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CEFEM DERIVATIVES.
NO159591C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF A THERAPEUTIC ACTIVE CARBOSTYRIC DERIVATIVE.
FI820392L (en) PROCEDURE FOR THE PHARMACEUTICAL PROTECTION OF ACTIVE 2-AMINO-3- (HALOBENZOYL) -METHYLPHENYL ETHYROR-ESTRAR OCH DERAS SATER
NO158739C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-PIPERAZINOPYRIMIDINE DERIVATIVES.
NO160511C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PHENYL-CYCLO-BUTAND DERIVATIVES.
NO160512C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOSTYRIC DERIVATIVES.
NO820112L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIDOINDOL DERIVATIVES
NO159793C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF A THERAPEUTIC ACTIVE 1- (4-ARYLCYCLOHEXYL) -PIPERIDE INGREDIENT.
NO813821L (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE INDOLINON DERIVATIVES
NO168478C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE VINYLTHIOACETAMIDO-OXACEPHALOSPORINE DERIVATIVES.
NO158800C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE INDENDER DERIVATIVES.
NO154052C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE QUINOLON DERIVATIVES.
NO158063C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE PYRAZOLO-PYRIDO-DIAZEPINE DERIVATIVES.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: A.H. ROBINS COMPANY, INCORPORATED